All In Biotech

Drug Trial Radar · NCT05585931

Effect of TPN171H on Spermatogenesis

Evaluate the Acute Effects of a Single Oral Dose of TPN171H on Semen Function in Healthy Male Subjects in China

Last checked: Nov 20, 2026Latest source record: Feb 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

18

Actual

Start

Nov 15, 2022

Primary completion

Dec 16, 2022

Study completion Dec 16, 2022

Sponsor

Lead sponsor
Vigonvita Life SciencesIndustry
Sponsor type
Industry
First posted
Oct 19, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a phaseⅠstudy to determine the acute effects of TPN171H on semen function in healthy male subjects.

Conditions

  • Erectile Dysfunction

Interventions

  • TPN171H 10mgDrug

    Subjects were given 10mg TPN171H tablet with 240 mL warm water under fasting condition.

  • TPN171H PlaceboDrug

    Subjects were given Placebo with 240 mL warm water under fasting condition.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effect on semen functionTime frame: 1.5 hours after taking the medicine
  2. Seminal plasma exposureTime frame: 1.5 hours after taking the medicine

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Peking University First Hospital

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.